Lexigen Pharmaceuticals Report issue

For profit Phase 1
Founded: Lexington MA United States (1991)
Status: Acquired by Merck KGaA (1998) → now Merck Serono (2006)

Organization Overview

First Clinical Trial
1999
NCT00002214
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
1999

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree